These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 19500510

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of continuous renal replacement therapy started at different time on patients with multiple organ dysfunction syndrome].
    Yao LQ, Jin ZC, Ji MS, Xia CY, Yu ZX, Liu J, Hu XL, Yan J.
    Zhonghua Yi Xue Za Zhi; 2011 Jun 28; 91(24):1663-7. PubMed ID: 21914312
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prothrombotic Effect of Anti-beta-2 Glycoprotein-1 Antibodies on the Expression of Tissue Factor, Thrombomodulin, and Plasminogen Activator Inhibitor-1 in Endothelial Cells.
    Rikarni, Dharma R, Tambunan KL, Isbagyo H, Dewi BE, Acang N, Setiabudy R, Aman AK.
    Acta Med Indones; 2015 Jan 28; 47(1):31-7. PubMed ID: 25948765
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of a low molecular weight heparin, bemiparin, and unfractionated heparin on hemostatic properties of endothelium.
    Pérez-Ruiz A, Montes R, Carrasco P, Rocha E.
    Clin Appl Thromb Hemost; 2002 Jan 28; 8(1):65-71. PubMed ID: 11991242
    [Abstract] [Full Text] [Related]

  • 8. Fasudil inhibits tissue factor and plasminogen activator Inhibitor-1 secretion by peripheral blood mononuclear cells in CAPD patients.
    Li W, Chen W, Xie M, Huang H, Su H, Han H, Zhang D, Zhang Y, Yang X, Xu W, Su Y, Wu W, Huang Y, Fu K, Wei J.
    Ren Fail; 2016 Oct 28; 38(9):1359-1363. PubMed ID: 27756191
    [Abstract] [Full Text] [Related]

  • 9. [Study on vascular endothelial injuries and inflammation related cytokines in patients with multiple organ dysfunction syndrome].
    Wang J, Qiao WH.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Feb 28; 18(2):82-4. PubMed ID: 16512635
    [Abstract] [Full Text] [Related]

  • 10. Dexamethasone increased plasminogen activator inhibitor-1 expression on human umbilical vein endothelial cells: an additive effect to tumor necrosis factor-alpha.
    Yamamoto Y, Ishizu A, Ikeda H, Otsuka N, Yoshiki T.
    Pathobiology; 2004 Feb 28; 71(6):295-301. PubMed ID: 15627839
    [Abstract] [Full Text] [Related]

  • 11. [Study on effect of anisodamine on expressions of tissue factor and plasminogen activator-1 inhibitor in vascular endothelial cells and its mechanisms].
    Ruan QR, Song JX, Deng ZD.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 May 28; 24(5):422-6. PubMed ID: 15199627
    [Abstract] [Full Text] [Related]

  • 12. [Application of continuous renal replacement therapy in the rescue of MODS patients].
    Cheng XM, Zhou QL, Deng SL, Chen LP, Zhang J.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug 28; 31(4):580-3. PubMed ID: 16951523
    [Abstract] [Full Text] [Related]

  • 13. Evidence that postoperative fibrinolytic shutdown is mediated by plasma factors that stimulate endothelial cell type I plasminogen activator inhibitor biosynthesis.
    Kassis J, Hirsh J, Podor TJ.
    Blood; 1992 Oct 01; 80(7):1758-64. PubMed ID: 1391943
    [Abstract] [Full Text] [Related]

  • 14. The tissue factor and plasminogen activator inhibitor type-1 response in pediatric sepsis-induced multiple organ failure.
    Green J, Doughty L, Kaplan SS, Sasser H, Carcillo JA.
    Thromb Haemost; 2002 Feb 01; 87(2):218-23. PubMed ID: 11858480
    [Abstract] [Full Text] [Related]

  • 15. Comparison of tissue factor expression and activity in foetal and adult endothelial cells.
    Collier MEW, Akinmolayan A, Goodall AH.
    Blood Coagul Fibrinolysis; 2017 Sep 01; 28(6):452-459. PubMed ID: 28151805
    [Abstract] [Full Text] [Related]

  • 16. Anti-thrombotic and pro-fibrinolytic effects of levosimendan in human endothelial cells in vitro.
    Krychtiuk KA, Kaun C, Hohensinner PJ, Stojkovic S, Seigner J, Kastl SP, Zuckermann A, Eppel W, Rauscher S, de Martin R, Maurer G, Huber K, Wojta J, Speidl WS.
    Vascul Pharmacol; 2017 Mar 01; 90():44-50. PubMed ID: 28192257
    [Abstract] [Full Text] [Related]

  • 17. Pitavastatin alters the expression of thrombotic and fibrinolytic proteins in human vascular cells.
    Markle RA, Han J, Summers BD, Yokoyama T, Hajjar KA, Hajjar DP, Gotto AM, Nicholson AC.
    J Cell Biochem; 2003 Sep 01; 90(1):23-32. PubMed ID: 12938153
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells.
    Hamaguchi E, Takamura T, Shimizu A, Nagai Y.
    J Pharmacol Exp Ther; 2003 Dec 01; 307(3):987-94. PubMed ID: 14534369
    [Abstract] [Full Text] [Related]

  • 20. Tissue factor and plasminogen activator inhibitor type 2 expression in human stimulated monocytes is inhibited by heparin.
    Pepe G, Giusti B, Attanasio M, Gori AM, Comeglio P, Martini F, Gensini G, Abbate R, Neri Serneri GG.
    Semin Thromb Hemost; 1997 Dec 01; 23(2):135-41. PubMed ID: 9200337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.